A 52-year-old man with a 20-year history of heavy alcohol consumption presents with jaundice, ascites, and hepatic encephalopathy. Liver biopsy confirms cirrhosis with active inflammation. Which drug is the first-line pharmacological agent to reduce mortality in alcoholic cirrhosis with hepatic encephalopathy?